Information Provided By:
Fly News Breaks for January 9, 2020
EL
Jan 9, 2020 | 06:50 EDT
Morgan Stanley analyst Dara Mohsenian reiterates an Overweight rating on Estee Lauder with a $220 price target saying the company's favorable mix shift to skin care is being underappreciated. The analyst expects expected short-term estimate upside relative to consensus given Estee's "conservative" guidance and longer term sales growth upside given the mix shift. The recent product category mix shift to skin care is much more favorable for Estee Lauder than the market is perceiving, giving investors another opportunity to participate in a favorable mix shift dynamic that has worked so well over the last few years, Mohsenian tells investors in a research note.
News For EL From the Last 2 Days
EL
Mar 28, 2024 | 16:23 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
EL
Mar 28, 2024 | 12:00 EDT
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
EL
Mar 28, 2024 | 05:51 EDT
BofA upgraded Estee Lauder to Buy from Neutral with a price target of $170, up from $160. The company currently has a range of initiatives to recovery profitability, sharpen product efficiency, and achieve more balance across channels and geographies, the analyst tells investors in a research note. The firm expects market share growth and operating leverage as Estee reduces its reliance on China and travel retail. It believes the company's earnings have bottomed.